Matrix metalloproteinase induction by relaxin causes cartilage matrix degradation in target synovial joints: Receptor profiles correlate with matrix turnover

Annals of the New York Academy of Sciences

Volumn 1160, Issue , 2009, Pages 322-328

  Kapila, Sunil ^a,b   Wang, Wei ^a   Uston, Karen ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

Degenerative joint disease; Estrogen; Extracellular matrix; Fibrocartilage; Matrix metalloproteinases; Progesterone; Relaxin

Indexed keywords

COLLAGEN; COLLAGENASE 3; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GELATINASE B; GLYCOSAMINOGLYCAN; HORMONE RECEPTOR; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROGESTERONE; RELAXIN; RXFP1 RECEPTOR; RXFP2 RECEPTOR; STROMELYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; BONE TURNOVER; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME METABOLISM; HORMONE RECEPTOR INTERACTION; NONHUMAN; OSTEOARTHRITIS; PUBIS SYMPHYSIS; TEMPOROMANDIBULAR JOINT;

ORYCTOLAGUS CUNICULUS;

EID: 64549087597     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.03830.x     Document Type: Conference Paper

References (34)

1. Felson, D.T. & M.C. Nevitt. 1998. The effects of estrogen on osteoarthritis. Curr. Opin. Rheumatol. 10: 269-272.
2. Von Korff, M., S.F. Dworkin, L. Le Resche, et al. 1988. An epidemiologic comparison of pain complaints. Pain 32: 173-183.
3. Warren, M.P. & J.L. Fried. 2001. Temporomandibu-lar disorders and hormones in women. Cells Tissues Organs 169: 187-192.
4. Lipton, J.A., J.A. Ship & D. Larach-Robinson. 1993. Estimated prevalence and distribution of reported orofacial pain in the United States. J. Am. Dent. Assoc. 124: 115-121.
5. Milam, S.B., T.B. Aufdemorte, P.J. Sheridan, et al. 1987. Sexual dimorphism in the distribution of estrogen receptors in the temporomandibular joint complex of the baboon. Oral Surg. Oral Med. Oral Pathol. 64: 527-532.
6. Abubaker, A.O., W.F. Raslan & G.C. Sotereanos. 1993. Estrogen and progesterone receptors in temporomandibular joint discs of symptomatic and asymptomatic persons: a preliminary study. J. Oral Maxillofac. Surg. 51: 1096-1100.
7. Yamada, K., K. Nozawa-Inoue, Y. Kawano, et al. 2003. Expression of estrogen receptor alpha (ER alpha) in the rat temporomandibular joint. Anat. Rec. A 274: 934-941.
8. Wang, W., T. Hayami & S. Kapila. 2008. Female hormone receptors are differentially expressed in mouse fibrocartilages. Osteoarthritis Cartilage Epub ahead of print, 17 October 2008 posting date.
9. Kapila, S. & Y Xie. 1998. Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthrodial joint fibrocar-tilaginous cells but not in synoviocytes. Lab. Invest. 78: 925-938.
10. Kapila, S. 2003. Does the relaxin, estrogen and matrix metalloproteinase axis contribute to degradation of TMJ fibrocartilage? J. Musculoskelet. Neuronal Interact. 3: 401-405.
11. Naqvi, T., T.T. Duong, G. Hashem, et al. 2005. Re-laxin's induction of metalloproteinases is associated with the loss of collagen and glycosaminoglycans in synovial joint fibrocartilaginous explants. Arthritis Res. Ther. 7: R1-R11.
12. Hashem, G., Q. Zhang, T. Hayami, et al. 2006. Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: Progesterone prevents matrix loss. Arthritis Res. Ther. 8: R98.
13. Samuel, C.S., L.J. Parry & R.J. Summers. 2003. Physiological or pathological: A role for relaxin in the cardiovascular system? Curr. Opin. Pharmacol. 3: 152-158.
14. Hwang, J.J., D. Macinga & E.A. Rorke. 1996. Relaxin modulates human cervical stromal cell activity. J. Clin. Endocrinol. Metab. 81: 3379-3384.
15. Mushayandebvu, T.I. & M.R. Rajabi. 1995. Relaxin stimulates interstitial collagenase activity in cultured uterine cervical cells from nonpregnant and pregnant but not immature guinea pigs; estradiol-17 beta restores relaxin's effect in immature cervical cells. Biol. Reprod. 53: 1030-1037.
16. Samuel, C.S., A. Butkus, J.P. Coghlan, et al. 1996. The effect of relaxin on collagen metabolism in the nonpregnant rat pubic symphysis: The influence of estrogen and progesterone in regulating relaxin activity. Endocrinology 137: 3884-3890.
17. Samuel, C.S., J.P. Coghlan & J.F. Bateman. 1998. Effects of relaxin, pregnancy and parturition on collagen metabolism in the rat pubic symphysis. J. Endocrinol. 159: 117-125.
18. Palejwala, S., D.E. Stein, G. Weiss, et al. 2001. Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology 142: 3405-3413.
19. Unemori, E.N. & E.P. Amento. 1990. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J. Biol. Chem. 265: 10681-10685.
20. Unemori, E.N., L.B. Pickford, A.L. Salles, et al. 1996. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J. Clin. Invest. 98: 2739-2745.
21. Potier, M., S.J. Elliott, I. Tack, et al. 2001. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J. Am. Soc. Nephrol. 12:241-251.
22. Marin-Castano, M.E., S.J. Elliott, M. Potier, et al. 2003. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 44: 50-59.
23. Di Nezza, L.A., TJobling & L.A. Salamonsen. 2003. Progestin suppresses matrix metalloproteinase production in endometrial cancer. Gynecol. Oncol. 89: 325-333.
24. Shimonovitz, S., A. Hurwitz, D. Hochner-Celnikier, et al. 1998. Expression of gelatinase B by trophoblast cells: Down-regulation by progesterone. Am. J. Obstet. Gynecol. 178: 457-461.
25. Keller, N.R., E. Sierra-Rivera, E. Eisenberg, et al. 2000. Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1α in human endometrial stromal cells. J. Clin. Endocrinol. Metab. 85: 1611-1619.
26. Salamonsen, L.A. & D.E. Woolley. 1999. Menstruation: Induction by matrix metalloproteinases and inflammatory cells. J. Reprod. Immunol. 44: 1-27.
27. Zhao, L., C.S. Samuel, G.W Tregear, et al. 2000. Collagen studies in late pregnant relaxin null mice. Biol. Reprod. 63: 697-703.
28. Hsu, S.Y., K. Nakabayashi, S. Nishi, et al. 2002. Activation of orphan receptors by the hormone relaxin. Science 295: 671-674.
29. Kumagai, J., S.Y. Hsu, H. Matsumi, et al. 2002. INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J. Biol. Chem. 277: 31283-31286.
30. Krajnc-Franken, M.A., A.J. van Disseldorp, J.E. Koenders, et al. 2004. Impaired nipple development and parturition in LGR7 knockout mice. Mol. Cell. Biol. 24: 687-696.
31. Grant-Tschudy, K.S. & C.R. Wira. 2004. Effect of estradiol on mouse uterine epithelial cell transep-ithelial resistance (TER). Am. J. Reprod. Immunol. 52: 252-262.
32. Lu, T., Y. Achari, P. Sciore, et al. 2006. Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 tran-scriptional regulatory site. Biochim. Biophys. Acta 1762: 719-731.
33. Stevens, T.A. & R. Meech. 2006. BARX2 and estrogen receptor-alpha (ESR1) coordi-nately regulate the production of alternatively spliced ESR1 isoforms and control breast cancer cell growth and invasion. Oncogene 25: 5426-5435.
34. Mizumoto, H., T. Saito, K. Ashikara, et al. 2002. Acceleration of invasive activity via matrix metallo-proteinases by transfection of the estrogen receptor-alpha gene in endometrial carcinoma cells. Int. J. Cancer 100:401-406.